Tasmania pilot to commence 1st March
Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on 1 March 2024. Endorsed pharmacists practising in approved premises will be able to prescribe antibiotics for uncomplicated urinary tract infections (UTIs). PDL continues to support the profession and members in the provision of professional services. PDL representatives have provided […]
Administering medicines by injection
In recent years, the pharmacy profession has seen significant expansion in the range of medicines that pharmacists can administer by injection. The scope has broadened to encompass different age groups and medicines, via different routes of injection. PDL guide to support pharmacists in the preparation and delivery of medicines by injection PDL has released a […]
Medicinal cannabis
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia. With this emerging field comes the need for comprehensive risk management considerations and strategies to ensure patient safety and regulatory compliance. The following explores some essential risk management considerations for pharmacists who are involved in this area of practice. […]
NSW Pharmacy Trial expression of interest closes 15 November
Pharmacists have limited time left to register their interest in their pharmacy taking part in the NSW Pharmacy Trial, with the expression of interest process scheduled to close at 5pm on 15 November 2023. The trial aims to allow appropriately trained pharmacists to provide community access to important medications and treatments that are usually only […]
Victorian Community Pharmacist Statewide Pilot announcement
Victorian pharmacists may be aware of the Community Pharmacist Statewide Pilot scheduled to go live towards the end of October. PDL continues to support the profession and members in the provision of professional services. PDL representatives have provided input to the Department of Health regarding risk management for this service. For those pharmacists considering joining […]
NSW/ACT Pharmacy Trial – extended supply of oral contraceptive pills by community pharmacists
The NSW Government-sponsored Pharmacy Trial for the extended supply of oral contraceptive pills (OCPs) by community pharmacists commenced on 27 September 2023. The trial aims to evaluate the implementation and impact of the provision of OCPs to applicable patients by approved pharmacists. The evaluation will consider patient safety, accessibility, patient acceptability and cost-effectiveness. The University […]
Administration of buprenorphine depot injection by WA pharmacists
On 13 September 2023, the WA Government released a new Structured Administration and Supply Arrangement (SASA) that authorises a registered pharmacist trained in the Community Program for Opioid Pharmacotherapy (CPOP) to administer depot buprenorphine when requested by the patient and prescriber. Checklist before providing this service Confirm insurance cover PDL continues to support the profession and […]
NSW/ACT UTI trial update
The NSW Government-sponsored clinical trial for the management of urinary tract infections (UTIs) by community pharmacists was expanded on 31 July 2023 to include more than 1000 pharmacies following the successful completion of the feasibility study. The ACT has now joined the trial with five ACT pharmacies participating. The trial aims to evaluate the implementation […]
WA Urinary Tract Infection service
On 4 August 2023, the WA Government announced the implementation of treatment of urinary tract infection (UTIs) by pharmacists. WA Health has issued a Structured Administration and Supply Arrangement (SASA) that authorises trained pharmacists working in community pharmacy to supply antibiotics for the treatment of urinary tract infections in eligible women aged between 18 and […]
NSW Urinary Tract Infection trial
As NSW pharmacists may be aware, NSW Health has announced the NSW Government-sponsored clinical trial for the management of urinary tract infections (UTIs) by community pharmacists. The trial aims to evaluate the effectiveness of pharmacists prescribing antibiotics to treat uncomplicated UTIs in eligible women aged 18 to 65 years (inclusive). The University of Newcastle is […]
